Our philosophy centers on helping men achieve optimal health through proven, regulated therapies
2001 Dec;27(8):817-27
Advances in Neural Information Processing Systems 28 , 22242232 (2015)
Introduction We focused on the stable gastric pentadecapeptide BPC 157 ( Thus, we suggest that one single application of the NO-synthase (NOS) blocker N(G)-nitro-L-arginine methyl ester (L-NAME) may induce retinal ischemia in rats, and that the stable pentadecapeptide BPC 157 may be the therapy, since it may interact with the NO-system and may counteract various adverse effects of L-NAME application (see In the previous eye research studies, BPC 157 counteracts atropine-mydriasis, but it also opposes an immediate and hour-lasting miotic effect of L-NAME in rats and guinea pigs, and participates in pupil control potentially via NO-mediated and cholinergic mechanisms ( This may be essential for the effective counteraction of the damaging effect of the retrobulbar L-NAME application
This means once you draw from the vial and recap it properly, the remaining solution stays protected not just for a few hours, but for up to 28 days under normal storage conditions
Physical form is a white to off-white lyophilized powder produced by chemical synthesis, with purity of not less than 98% as determined by HPLC